Another phase III, randomized, open-label, non-inferiority, head-to-head trial, AWARD-6, evaluated dulaglutide (1.5 mg) versus liraglutide (1.8 mg) in patients with T2DM
Employment offers are made on the basis of qualifications , and without regard to race, sex, religion, national or ethnic origin, disability, age, veteran status, or sexual orientation
Pfeiffer, R
Researchers from Stanford University tested the effects of N-acetyl cysteine supplementation on autism symptoms in children
Taking it in the morning can provide antioxidant protection for the day ahead